| Medical and Health Sciences | Lifetime | 807 | US 415 | 99.96 |
| Pulmonary and Respiratory Medicine | Lifetime | 50 | US 26 | 99.93 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 67 | US 37 | 99.82 |
| Biomedical Engineering | Lifetime | 962 | US 285 | 98.55 |
| Cancer Research | Lifetime | 527 | US 273 | 96.68 |
| Biotechnology | Lifetime | 468 | US 130 | 92.56 |
| Pulmonary and Respiratory Medicine | 2021-2025 | 155 | US 52 | 98.90 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 198 | US 66 | 96.27 |
| Oncology | 2021-2025 | 452 | US 202 | 94.34 |
| Immunology | 2021-2025 | 620 | US 222 | 81.82 |
| Cancer Research | 2021-2025 | 317 | US 120 | 80.83 |
| MRI in cancer diagnosis | Lifetime | 2 | US 2 | 99.92 |
| Radiomics and Machine Learning in Medical Imaging | Lifetime | 12 | US 5 | 99.88 |
| Cancer Research and Treatments | Lifetime | 32 | US 20 | 99.63 |
| Prostate Cancer Diagnosis and Treatment | Lifetime | 25 | US 20 | 99.86 |
| Nanoplatforms for cancer theranostics | Lifetime | 52 | US 11 | 99.74 |
| Prostate Cancer Treatment and Research | Lifetime | 45 | US 34 | 99.78 |
| Renal cell carcinoma treatment | Lifetime | 39 | US 31 | 99.73 |
| Cancer, Hypoxia, and Metabolism | Lifetime | 97 | US 47 | 99.62 |
| Renal and related cancers | Lifetime | 45 | US 33 | 99.62 |
| Radiopharmaceutical Chemistry and Applications | Lifetime | 76 | US 45 | 99.30 |
| Medical Imaging Techniques and Applications | Lifetime | 244 | US 119 | 98.96 |
| Urologic and reproductive health conditions | Lifetime | 75 | US 43 | 99.45 |
| Genetic and Kidney Cyst Diseases | Lifetime | 58 | US 32 | 98.76 |
| Photodynamic Therapy Research Studies | Lifetime | 84 | US 25 | 98.66 |
| Pediatric Urology and Nephrology Studies | Lifetime | 144 | US 94 | 98.77 |
| Renal and Vascular Pathologies | Lifetime | 189 | US 112 | 98.60 |
| Advanced MRI Techniques and Applications | Lifetime | 518 | US 254 | 98.70 |
| Lanthanide and Transition Metal Complexes | Lifetime | 472 | US 111 | 97.58 |
| Angiogenesis and VEGF in Cancer | Lifetime | 570 | US 256 | 96.71 |
| Medical Image Segmentation Techniques | Lifetime | 448 | US 165 | 96.81 |
| Medical Imaging and Pathology Studies | Lifetime | 919 | US 404 | 95.88 |
| Adrenal and Paraganglionic Tumors | Lifetime | 480 | US 171 | 96.03 |
| Neuroblastoma Research and Treatments | Lifetime | 955 | US 451 | 95.70 |
| Dendrimers and Hyperbranched Polymers | Lifetime | 387 | US 78 | 94.90 |
| Photoacoustic and Ultrasonic Imaging | Lifetime | 978 | US 389 | 94.69 |
| Medical Imaging and Analysis | Lifetime | 768 | US 320 | 93.84 |
| Tuberous Sclerosis Complex Research | Lifetime | 256 | US 142 | 90.88 |
| Lymphatic System and Diseases | Lifetime | 975 | US 326 | 85.82 |
| Lymphatic Disorders and Treatments | Lifetime | 426 | US 182 | 70.26 |
| Prostate Cancer Diagnosis and Treatment | 2021-2025 | 80 | US 19 | 98.75 |
| Prostate Cancer Treatment and Research | 2021-2025 | 128 | US 49 | 98.54 |
| Radiomics and Machine Learning in Medical Imaging | 2021-2025 | 585 | US 113 | 96.20 |
| Peptidase Inhibition and Analysis | 2021-2025 | 219 | US 64 | 95.25 |
| Radiopharmaceutical Chemistry and Applications | 2021-2025 | 207 | US 62 | 94.88 |
| Urologic and reproductive health conditions | 2021-2025 | 100 | US 22 | 93.65 |
| MRI in cancer diagnosis | 2021-2025 | 305 | US 68 | 91.65 |
| Cancer, Hypoxia, and Metabolism | 2021-2025 | 564 | US 130 | 89.90 |
| Cancer, Lipids, and Metabolism | 2021-2025 | 400 | US 92 | 90.75 |
| Medical Imaging Techniques and Applications | 2021-2025 | 760 | US 210 | 92.29 |
| Photodynamic Therapy Research Studies | 2021-2025 | 223 | US 19 | 90.88 |
| Cancer Research and Treatments | 2021-2025 | 379 | US 112 | 87.15 |
| Protease and Inhibitor Mechanisms | 2021-2025 | 195 | US 28 | 82.16 |
| Angiogenesis and VEGF in Cancer | 2021-2025 | 589 | US 125 | 64.67 |
| Cancer, Stress, Anesthesia, and Immune Response | 2021-2025 | 874 | US 218 | 58.30 |
